×
Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Biopsy Devices Market Trends

ID: MRFR/MED/1652-CR
80 Pages
Rahul Gotadki
March 2023

Biopsy Devices Market Research Report: Size, Share, Trend Analysis By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles [Vacuum-Assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices, Core Needle Biopsy (CNB) Devices], Biopsy Forceps, Localization Wires, and Others), By Applications (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, and Others), By Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic Guided Biopsy, MRI-Guided Biopsy, CT Guided Biopsy, and Others), By End Users (Hospitals & Clinics, Diagnostic & Imaging Centers, Academic & Research Institutes and Others), By Region (North America, Europe, Asia-Pacific, And Rest Of The World)) - Growth Outlook & Industry Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Biopsy Devices Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Biopsy Devices Market

The biopsy devices market is encountering eminent development, pushed by progressions in symptomatic advancements and a rising pervasiveness of different diseases requiring precise tissue testing. Biopsy methods are critical for diagnosing and observing circumstances like cancer, and the market reflects progressing developments in biopsy gadget advancements. There is a perceivable shift towards insignificantly obtrusive biopsy strategies, driven by persistent inclinations and the desire to reduce procedural concern. Devices like fine-needle aspiration (FNA) and center needle biopsy are gaining visibility, offering less intrusive options in contrast to conventional careful operations. The approach of fluid biopsy is changing the analytic scene. Fluid biopsy devices empower the recognition of flowing growth cells and nucleic acids in organic liquids, offering a less obtrusive option in contrast to conventional tissue biopsies. This approach is especially encouraging for checking cancer movement and therapy reaction. The biopsy devices market is seeing a surge in applications inside the area of oncology. With the rising frequency of cancer, there is a developing interest for biopsy devices to aid in the early identification, organizing, and customized therapy of different cancer types. Advanced mechanics and AI are being integrated into biopsy strategies to upgrade accuracy and effectiveness. Mechanical helped biopsy devices empower more exact focusing of sores, while AI calculations help with breaking down biopsy results, adding to quicker and more solid determinations. There is a recognizable pattern towards the reception of expendable biopsy devices. These single-use devices decrease the gamble of defilement, improve patient security, and work on the general biopsy process. The shift towards disposables is likewise determined by cost-viability and comfort for medical services suppliers. Biopsy gadget makers are creating arrangements tailored to clear growth types. Recreated biopsy devices upgrade the inspecting system for various cancers, guaranteeing that medical care experts obtain adequate and delegate tissue tests for precise finding and therapy arranging.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

What is the projected market valuation of the Biopsy Devices Market by 2035?

The Biopsy Devices Market is projected to reach a valuation of 5.182 USD Billion by 2035.

What was the market valuation of the Biopsy Devices Market in 2024?

In 2024, the overall market valuation was 2.81 USD Billion.

What is the expected CAGR for the Biopsy Devices Market during the forecast period 2025 - 2035?

The expected CAGR for the Biopsy Devices Market during the forecast period 2025 - 2035 is 5.72%.

Which segment of biopsy devices is projected to have the highest growth by 2035?

Biopsy Guns are projected to grow from 0.84 USD Billion in 2024 to 1.56 USD Billion by 2035.

How do the revenues of breast biopsy devices compare to prostate biopsy devices in 2024?

In 2024, breast biopsy devices generated 0.84 USD Billion, while prostate biopsy devices accounted for 0.68 USD Billion.

Market Summary

As per Market Research Future analysis, the Biopsy Devices Market Size was estimated at 2.81 USD Billion in 2024. The Biopsy Devices industry is projected to grow from 2.971 USD Billion in 2025 to 5.182 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.72% during the forecast period 2026 - 2035

Key Market Trends & Highlights

The Biopsy Devices Market is experiencing robust growth driven by technological advancements and increasing demand for minimally invasive procedures.

  • Technological advancements are enhancing the precision and efficiency of biopsy devices, particularly in North America. The rising demand for minimally invasive procedures is propelling the adoption of biopsy guns, which remain the largest segment in the market. In Asia-Pacific, the focus on early detection is driving growth in the biopsy guidance system segment, which is currently the fastest-growing. Key market drivers include the increasing incidence of cancer and the growing geriatric population, both of which are fueling demand for effective biopsy solutions.

Market Size & Forecast

2024 Market Size 2.81 (USD Billion)
2035 Market Size 5.182 (USD Billion)
CAGR (2025 - 2035) 5.72%
Largest Regional Market Share in 2024 North America

Major Players

<p><a title="Becton Dickinson and Company" href="https://www.bd.com/en-in/products-and-solutions/products/product-families/mission-disposable-core-biopsy-instrument" target="_blank" rel="noopener">Becton Dickinson and Company</a> (US), Boston Scientific Corporation (US), <a title="Medtronic plc" href="https://www.medtronic.com/en-us/healthcare-professionals/products/lung-health-thoracic-surgery/pulmonary-biopsy-tools.html" target="_blank" rel="noopener">Medtronic plc</a> (IE), Hologic, Inc. (US), Thermo Fisher Scientific Inc. (US), Abbott Laboratories (US), Siemens Healthineers AG (DE), Johnson &amp; Johnson (US), Cook Medical Incorporated (US)</p>

Market Trends

The Biopsy Devices Market is currently experiencing a transformative phase, driven by advancements in technology and an increasing emphasis on early disease detection. Innovations in imaging techniques and minimally invasive procedures are enhancing the accuracy and efficiency of biopsies, thereby improving patient outcomes. Furthermore, the growing prevalence of cancer and other chronic diseases is propelling demand for biopsy devices, as healthcare providers seek reliable methods for diagnosis. This market is characterized by a diverse range of products, including needle-based devices, surgical instruments, and imaging-guided systems, each contributing to the overall growth and evolution of the sector. In addition to technological advancements, regulatory support and increased funding for research are likely to play pivotal roles in shaping the Biopsy Devices Market. As healthcare systems worldwide prioritize patient-centered care, the focus on developing user-friendly and efficient biopsy solutions is becoming more pronounced. The integration of artificial intelligence and machine learning into diagnostic processes may further enhance the capabilities of biopsy devices, suggesting a future where precision medicine becomes the norm. Overall, the Biopsy Devices Market appears poised for sustained growth, driven by innovation and a commitment to improving diagnostic accuracy and patient care.

Technological Advancements

The Biopsy Devices Market is witnessing rapid technological advancements that enhance the precision and efficiency of diagnostic procedures. Innovations such as robotic-assisted systems and advanced imaging techniques are streamlining the biopsy process, allowing for more accurate tissue sampling and reduced patient discomfort.

Rising Demand for Minimally Invasive Procedures

There is a growing preference for minimally invasive procedures within the Biopsy Devices Market, as patients and healthcare providers alike seek alternatives that reduce recovery time and complications. This trend is likely to drive the development of new devices that prioritize patient safety and comfort.

Increased Focus on Early Detection

The emphasis on early disease detection is becoming increasingly prominent in the Biopsy Devices Market. As healthcare systems recognize the importance of timely diagnosis, there is a corresponding rise in the demand for advanced biopsy solutions that facilitate early intervention and improve treatment outcomes.

Biopsy Devices Market Market Drivers

Rising Incidence of Cancer

The alarming rise in cancer incidence is a significant factor driving the Biopsy Devices Market. As cancer remains one of the leading causes of mortality worldwide, the need for effective diagnostic tools is more pressing than ever. Biopsy procedures are essential for confirming cancer diagnoses and determining appropriate treatment plans. Recent data indicates that the global cancer burden is expected to increase, with millions of new cases diagnosed annually. This surge in cancer cases is likely to propel the demand for various biopsy devices, including needle biopsies and surgical biopsies. Consequently, the market is poised for growth, as healthcare providers seek to enhance their diagnostic capabilities in response to this escalating health crisis.

Growing Geriatric Population

The aging population is a crucial driver for the Biopsy Devices Market, as older individuals are more susceptible to various health conditions, including cancer. As the geriatric demographic continues to expand, the demand for diagnostic procedures, including biopsies, is expected to increase correspondingly. This trend is particularly relevant in developed regions, where healthcare systems are adapting to cater to the needs of an aging populace. Market forecasts indicate that the biopsy devices segment catering to geriatric patients will witness substantial growth, driven by the necessity for accurate and timely diagnoses in this vulnerable group. The implications of this demographic shift are profound, suggesting a sustained demand for innovative biopsy solutions.

Technological Advancements in Biopsy Devices

The Biopsy Devices Market is experiencing a notable transformation due to rapid technological advancements. Innovations such as automated biopsy systems and imaging-guided techniques are enhancing the precision and efficiency of biopsy procedures. For instance, the integration of artificial intelligence in imaging technologies is facilitating real-time analysis, which may lead to improved diagnostic accuracy. Furthermore, the development of advanced needle technologies, such as core needle and vacuum-assisted biopsy devices, is likely to reduce patient discomfort and recovery time. According to recent data, the market for automated biopsy devices is projected to grow at a compound annual growth rate of approximately 8% over the next five years, indicating a robust demand for these advanced solutions.

Increased Focus on Early Detection of Diseases

The Biopsy Devices Market is also being propelled by an increased focus on early detection of diseases, particularly cancer. Early diagnosis is critical for improving patient outcomes, and biopsy procedures play a pivotal role in this process. As healthcare systems worldwide emphasize preventive care, the demand for biopsy devices is likely to surge. Recent statistics indicate that the incidence of various cancers is on the rise, necessitating the need for effective diagnostic tools. Consequently, the market for biopsy devices is projected to expand, with a significant portion of growth attributed to the rising number of screening programs and initiatives aimed at early disease detection.

Rising Demand for Minimally Invasive Procedures

The increasing preference for minimally invasive procedures is significantly influencing the Biopsy Devices Market. Patients and healthcare providers alike are gravitating towards techniques that minimize surgical trauma and expedite recovery. This trend is particularly evident in oncology, where early and accurate diagnosis is crucial. As a result, devices that facilitate minimally invasive biopsies, such as fine needle aspiration and endoscopic ultrasound-guided biopsies, are witnessing heightened adoption. Market analysis suggests that the segment of minimally invasive biopsy devices is expected to account for a substantial share of the overall market, driven by the growing awareness of patient-centric care and the benefits of reduced hospitalization.

Market Segment Insights

By Type: Biopsy Guns (Largest) vs. Biopsy Guidance System (Fastest-Growing)

<p>The Biopsy Devices Market segments into Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps, Localization Wires, and Others. Among these, Biopsy Guns hold the largest market share due to their efficiency and widespread usage in various procedures. Following this, Biopsy Guidance Systems are emerging rapidly, demonstrating remarkable growth driven by advancements in imaging technologies that enhance precision in targeting lesion sites. As the demand for minimally invasive procedures increases, the growth of Biopsy Guidance Systems is particularly notable. Factors such as the rising prevalence of cancer and the emphasis on early diagnosis are propelling the adoption of advanced biopsy technologies. Additionally, the integration of robotic assistance and augmented reality in biopsy guidance is expected to further boost market expansion, making it a key focus area for investment and development.</p>

<p>Biopsy Guns (Dominant) vs. Biopsy Needles (Emerging)</p>

<p>Biopsy Guns are pivotal in the Biopsy Devices Market, offering both speed and accuracy, making them the dominant choice for clinicians. These devices are characterized by their ability to rapidly obtain tissue samples, significantly reducing procedure time while ensuring quality. In contrast, Biopsy Needles, while traditionally viewed as a staple in biopsy procedures, are evolving as an emerging competitor. The development of specialized needles designed for specific types of tissue sampling is enhancing their market appeal. The versatility and adaptability of Biopsy Needles in various diagnostic scenarios position them as essential tools within the market, leading to increased manufacturer focus on innovation for enhanced performance.</p>

By Application: Breast Biopsy (Largest) vs. Prostate Biopsy (Fastest-Growing)

<p>The biopsy devices market is diverse, with various applications serving different medical needs. Among these, Breast Biopsy holds the largest market share, largely attributed to the high prevalence of breast cancer and the increasing awareness of early detection. Prostate Biopsy, while holding a smaller portion, has shown remarkable growth potential due to an uptick in prostate cancer diagnoses and advancements in procedural techniques that enhance patient outcomes. This shift is indicative of changing healthcare priorities and diagnostic trends in urology. Notably, growth trends within the Biopsy Devices Market indicate a shift towards minimally invasive procedures across all application segments. However, Prostate Biopsy has emerged as the fastest-growing segment, driven by innovations in imaging technologies and needle biopsy techniques that allow for more accurate diagnoses with less patient discomfort. Furthermore, the increasing aging population and rising cancer incidence rates further fuel the demands for advanced biopsy devices, promoting growth particularly in prostate and liver biopsy procedures.</p>

<p>Breast Biopsy (Dominant) vs. Lung Biopsy (Emerging)</p>

<p>Breast Biopsy stands out as the dominant application in the biopsy devices market, primarily due to the prevalent focus on early cancer detection and the successful implementation of screening programs. The sophistication of devices used, including stereotactic and ultrasound-guided techniques, enhances precision and patient safety, cementing its leading position. Conversely, Lung Biopsy is categorized as an emerging application amid rising lung cancer cases and enhanced diagnostic protocols. Newer methods, like navigation bronchoscopy, offer less invasive solutions and higher accuracy for lung tissue sampling. While Breast Biopsy leads in familiarity and routine use, Lung Biopsy's potential is rapidly unfolding as healthcare systems adapt to the growing need for effective lung cancer management, marking a shift in biopsy device utilization towards lung-related applications.</p>

By Guidance Technique: Ultrasound-Guided Biopsy (Largest) vs. MRI-Guided Biopsy (Fastest-Growing)

<p>The Guidance Technique segment in the Biopsy Devices Market showcases a diverse array of methodologies, with Ultrasound-Guided Biopsy leading the way as the predominant technique. This method is widely utilized due to its cost-effectiveness and real-time imaging capabilities, capturing a significant market share. Stereotactic Guided Biopsy follows closely, offering precise targeting for lesions, while MRI-Guided Biopsy and CT Guided Biopsy are also notable participants, addressing specific diagnostic needs. Others include emerging techniques that contribute to the innovative landscape of biopsy technologies. In terms of growth trends, MRI-Guided Biopsy is emerging as the fastest-growing segment, driven by advancements in imaging technology and increasing demand for non-invasive procedures. The overall trend is towards enhancing accuracy and reducing the risks associated with traditional biopsies. Factors such as rising cancer incidence, the aging population, and improved healthcare spending are propelling the adoption of these advanced imaging-guided techniques, fostering competition and innovation within the market.</p>

<p>Ultrasound-Guided Biopsy (Dominant) vs. Stereotactic Guided Biopsy (Emerging)</p>

<p>Ultrasound-Guided Biopsy is recognized as the dominant force in the Guidance Technique segment, primarily due to its widespread application and effectiveness in various clinical scenarios. This technique offers real-time imaging, allowing for immediate adjustments during the procedure, which enhances accuracy and patient outcomes. Conversely, Stereotactic Guided Biopsy is seen as an emerging technique within this segment. It is particularly advantageous for sampling from deep-seated lesions, leveraging advanced imaging systems for precision. Both techniques are critical in the biopsies landscape, addressing unique clinical needs while driving innovation and enhancing procedural efficacy.</p>

By End User: Hospitals & Clinics (Largest) vs. Diagnostic & Imaging Centers (Fastest-Growing)

<p>In the Biopsy Devices Market, Hospitals &amp; Clinics hold the largest share, driven by their extensive use of biopsy procedures for diagnosing various conditions. This segment benefits from the high patient footfall and advanced medical technology adoption in healthcare facilities. On the other hand, Diagnostic &amp; Imaging Centers are emerging as a significant player, utilizing cutting-edge imaging techniques to enhance the precision of biopsy processes, thus steadily capturing a larger market share.</p>

<p>Hospitals &amp; Clinics (Dominant) vs. Diagnostic &amp; Imaging Centers (Emerging)</p>

<p>Hospitals &amp; Clinics represent the dominant end-user segment in the Biopsy Devices Market, leveraging their robust infrastructure and specialized personnel to conduct a vast number of biopsy procedures. They utilize a wide range of biopsy devices, including needle biopsies and core biopsies, ensuring comprehensive patient care. In contrast, Diagnostic &amp; Imaging Centers are swiftly emerging, capitalizing on technological advancements such as MRI and CT imaging to improve diagnostic accuracy. Their focus on non-invasive biopsy methods appeals to patients seeking less discomfort, contributing to their rapid growth as a preferred option for diagnostic services in the healthcare landscape.</p>

Get more detailed insights about Biopsy Devices Market Research Report - Global Forecast to 2035

Regional Insights

North America : Market Leader in Innovation

North America is the largest market for biopsy devices, holding approximately 45% of the global share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cancer, and rising demand for minimally invasive procedures. Regulatory support from agencies like the FDA further catalyzes innovation and market expansion, ensuring that new technologies are swiftly integrated into clinical practice. The United States is the primary contributor to this market, with key players such as Becton Dickinson and Company, Boston Scientific Corporation, and Hologic, Inc. leading the competitive landscape. The presence of established healthcare systems and significant investments in research and development bolster the market. Additionally, the focus on early diagnosis and personalized medicine enhances the demand for advanced biopsy devices, solidifying North America's position as a market leader.

Europe : Emerging Market with Growth Potential

Europe is witnessing significant growth in the biopsy devices market, accounting for approximately 30% of the global share. The region benefits from a robust healthcare system, increasing awareness of early cancer detection, and supportive regulatory frameworks. The European Medicines Agency (EMA) plays a crucial role in ensuring the safety and efficacy of medical devices, which fosters innovation and market growth. Leading countries in this region include Germany, France, and the UK, where major players like Siemens Healthineers AG and Medtronic plc are actively involved. The competitive landscape is characterized by a mix of established companies and emerging startups, focusing on technological advancements and patient-centric solutions. The increasing incidence of cancer and the demand for precise diagnostic tools are driving the adoption of biopsy devices across Europe.

Asia-Pacific : Rapidly Growing Healthcare Sector

Asia-Pacific is emerging as a significant player in the biopsy devices market, holding around 20% of the global share. The region's growth is fueled by rising healthcare expenditures, increasing awareness of cancer screening, and advancements in medical technology. Countries like China and India are witnessing rapid improvements in healthcare infrastructure, which is expected to further boost market demand for biopsy devices. China is the largest market in this region, with a growing number of healthcare facilities and a rising population of cancer patients. The competitive landscape includes both local manufacturers and international players, such as Abbott Laboratories and Thermo Fisher Scientific Inc. The focus on improving diagnostic accuracy and patient outcomes is driving innovation in biopsy technologies, making Asia-Pacific a key region for future growth.

Middle East and Africa : Untapped Market with Opportunities

The Middle East and Africa (MEA) region is gradually emerging in the biopsy devices market, currently holding about 5% of the global share. The growth is primarily driven by increasing healthcare investments, rising awareness of cancer prevalence, and the need for advanced diagnostic tools. Governments in the region are implementing initiatives to improve healthcare access, which is expected to enhance market dynamics in the coming years. Countries like South Africa and the UAE are leading the market, with a growing number of healthcare facilities and increasing demand for innovative medical technologies. The competitive landscape is evolving, with both local and international companies vying for market share. The focus on improving healthcare outcomes and expanding access to diagnostic services presents significant opportunities for growth in the biopsy devices market in MEA.

Key Players and Competitive Insights

The Biopsy Devices Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cancer. Key players such as Becton Dickinson and Company (US), Hologic, Inc. (US), and Medtronic plc (IE) are strategically positioned to leverage innovation and expand their market presence. Becton Dickinson and Company (US) focuses on enhancing its product portfolio through continuous research and development, while Hologic, Inc. (US) emphasizes its commitment to women's health, particularly in breast biopsy technologies. Medtronic plc (IE) appears to be concentrating on integrating digital solutions into its biopsy devices, thereby enhancing diagnostic accuracy and patient outcomes. Collectively, these strategies foster a competitive environment that prioritizes innovation and patient-centric solutions. In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The Biopsy Devices Market is moderately fragmented, with several players vying for market share. This fragmentation allows for diverse offerings, yet the influence of key players remains substantial, as they set benchmarks for quality and technological advancement. The collective actions of these companies shape a competitive structure that encourages ongoing innovation and responsiveness to market demands. In August 2025, Hologic, Inc. (US) announced the launch of its latest biopsy device, which incorporates AI-driven imaging technology to enhance precision in tissue sampling. This strategic move not only positions Hologic as a leader in technological integration but also addresses the growing demand for accurate diagnostics in oncology. The introduction of AI capabilities is likely to attract healthcare providers seeking to improve patient outcomes through advanced diagnostic tools. In September 2025, Medtronic plc (IE) revealed a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its biopsy devices. This collaboration aims to streamline the biopsy process and facilitate real-time data sharing between patients and healthcare professionals. By embracing telehealth, Medtronic is not only enhancing patient engagement but also adapting to the evolving healthcare landscape, which increasingly favors remote solutions. In July 2025, Becton Dickinson and Company (US) expanded its manufacturing facility in the United States to increase production capacity for its biopsy devices. This expansion reflects the company's commitment to meeting rising global demand and underscores its strategy of localizing production to enhance supply chain reliability. Such initiatives are crucial in a market where timely access to innovative devices can significantly impact patient care. As of October 2025, the Biopsy Devices Market is witnessing trends that emphasize digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming increasingly prevalent, as companies recognize the value of collaboration in driving innovation and expanding market reach. The competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, quality, and supply chain resilience, suggesting a future where innovation and reliability are paramount.

Key Companies in the Biopsy Devices Market include

Industry Developments

  • Q2 2024: BD Launches New UltraCore™ Single-Use Biopsy Device for Improved Patient Safety Becton, Dickinson and Company (BD) announced the launch of its UltraCore™ single-use biopsy device, designed to enhance procedural safety and reduce infection risk in tissue sampling procedures.
  • Q2 2024: Hologic Receives FDA Clearance for Brevera® Breast Biopsy System with CorLumina® Imaging Technology Hologic, Inc. received FDA clearance for its Brevera® Breast Biopsy System with CorLumina® Imaging Technology, enabling real-time imaging and improved workflow for breast tissue sampling.
  • Q2 2024: Argon Medical Devices Announces Launch of SuperCore™ Advantage Biopsy Instrument Argon Medical Devices launched the SuperCore™ Advantage Biopsy Instrument, a new device designed to provide enhanced tissue yield and ease of use for clinicians performing soft tissue biopsies.
  • Q2 2024: Merit Medical Launches Temno Evolution Biopsy Device with Single-Use Design Merit Medical Systems, Inc. introduced the Temno Evolution Biopsy Device, featuring a single-use, ergonomically contoured body to improve procedural safety and reduce the risk of cross-contamination.
  • Q3 2024: INRAD, Inc. Announces FDA 510(k) Clearance for New MRI-Guided Biopsy Needle INRAD, Inc. received FDA 510(k) clearance for its new MRI-guided biopsy needle, expanding its portfolio of minimally invasive diagnostic tools for soft tissue sampling.
  • Q3 2024: Siemens Healthineers and BioVentrix Announce Strategic Partnership to Advance Image-Guided Biopsy Solutions Siemens Healthineers and BioVentrix entered a strategic partnership to co-develop advanced image-guided biopsy solutions, aiming to improve diagnostic accuracy and patient outcomes.
  • Q3 2024: Boston Scientific Appoints New President of Interventional Oncology and Biopsy Devices Market Division Boston Scientific Corporation announced the appointment of a new president to lead its Interventional Oncology and Biopsy Devices Market Division, signaling a renewed focus on innovation and market expansion.
  • Q4 2024: MDxHealth Announces CE Mark for SelectMDx Prostate Biopsy Device in Europe MDxHealth received CE Mark approval for its SelectMDx Prostate Biopsy Device, allowing commercialization and clinical use across the European Union.
  • Q4 2024: Cook Medical Opens New Biopsy Device Manufacturing Facility in Indiana Cook Medical opened a new manufacturing facility in Indiana dedicated to the production of biopsy devices, aiming to meet growing demand and improve supply chain resilience.
  • Q1 2025: Veracyte Announces $50 Million Series D Funding to Expand Biopsy Diagnostics Portfolio Veracyte, Inc. raised $50 million in Series D funding to accelerate the development and commercialization of its biopsy diagnostics portfolio, including new minimally invasive tissue sampling technologies.
  • Q1 2025: Roche Receives FDA Approval for NAVIFY® Biopsy Workflow Solution Roche announced FDA approval for its NAVIFY® Biopsy Workflow Solution, a digital platform designed to streamline and standardize the biopsy process in clinical settings.
  • Q2 2025: BD Acquires BiopsyTech, Expanding Portfolio of Minimally Invasive Biopsy Devices Market Becton, Dickinson and Company (BD) completed the acquisition of BiopsyTech, a company specializing in minimally invasive biopsy devices, to strengthen its position in the global biopsy devices market.

Future Outlook

Biopsy Devices Market Future Outlook

<p>The Biopsy Devices Market is projected to grow at a 5.72% CAGR from 2025 to 2035, driven by technological advancements, increasing cancer prevalence, and rising demand for minimally invasive procedures.</p>

New opportunities lie in:

  • <p>Development of AI-integrated biopsy systems for enhanced diagnostic accuracy. Expansion of telehealth services for remote biopsy consultations. Investment in biodegradable biopsy devices to meet sustainability goals.</p>

<p>By 2035, the Biopsy Devices Market is expected to achieve substantial growth, driven by innovation and evolving healthcare needs.</p>

Market Segmentation

Biopsy Devices Market Type Outlook

  • Biopsy Guns
  • Biopsy Guidance System
  • Biopsy Needles
  • Biopsy Forceps
  • Localization Wires
  • Others

Biopsy Devices Market End User Outlook

  • Hospitals & Clinics
  • Diagnostic & Imaging Centers
  • Academic & Research Institutes
  • Others

Biopsy Devices Market Application Outlook

  • Breast Biopsy
  • Prostate Biopsy
  • Liver Biopsy
  • Lung Biopsy
  • Gynecological Biopsy
  • Others

Biopsy Devices Market Guidance Technique Outlook

  • Ultrasound-Guided Biopsy
  • Stereotactic Guided Biopsy
  • MRI-Guided Biopsy
  • CT Guided Biopsy
  • Others

Report Scope

MARKET SIZE 2024 2.81(USD Billion)
MARKET SIZE 2025 2.971(USD Billion)
MARKET SIZE 2035 5.182(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.72% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2026 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Becton Dickinson and Company (US), Boston Scientific Corporation (US), Medtronic plc (IE), Hologic, Inc. (US), Thermo Fisher Scientific Inc. (US), Abbott Laboratories (US), Siemens Healthineers AG (DE), Johnson & Johnson (US), Cook Medical Incorporated (US)
Segments Covered Product Type, Applications, Guidance Technique, End Users, Region
Key Market Opportunities Advancements in minimally invasive techniques enhance growth potential in the Biopsy Devices Market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the biopsy devices market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Biopsy Devices Market by 2035?

The Biopsy Devices Market is projected to reach a valuation of 5.182 USD Billion by 2035.

What was the market valuation of the Biopsy Devices Market in 2024?

In 2024, the overall market valuation was 2.81 USD Billion.

What is the expected CAGR for the Biopsy Devices Market during the forecast period 2025 - 2035?

The expected CAGR for the Biopsy Devices Market during the forecast period 2025 - 2035 is 5.72%.

Which segment of biopsy devices is projected to have the highest growth by 2035?

Biopsy Guns are projected to grow from 0.84 USD Billion in 2024 to 1.56 USD Billion by 2035.

How do the revenues of breast biopsy devices compare to prostate biopsy devices in 2024?

In 2024, breast biopsy devices generated 0.84 USD Billion, while prostate biopsy devices accounted for 0.68 USD Billion.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. EXECUTIVE SUMMARY
      1. Market Overview
      2. Key Findings
      3. Market Segmentation
      4. Competitive Landscape
      5. Challenges and Opportunities
      6. Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. MARKET INTRODUCTION
      1. Definition
      2. Scope of the study
    2. RESEARCH METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
      5. Forecasting Model
      6. Market Size Estimation
      7. Data Triangulation
      8. Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS
    1. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    2. MARKET FACTOR ANALYSIS
      1. Value chain Analysis
      2. Porter's Five Forces Analysis
      3. COVID-19 Impact Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. Biopsy Devices Market, BY Type (USD Billion)
      1. Biopsy Guns
      2. Biopsy Guidance System
      3. Biopsy Needles
      4. Biopsy Forceps
      5. Localization Wires
      6. Others
    2. Biopsy Devices Market, BY Application (USD Billion)
      1. Breast Biopsy
      2. Prostate Biopsy
      3. Liver Biopsy
      4. Lung Biopsy
      5. Gynecological Biopsy
      6. Others
    3. Biopsy Devices Market, BY Guidance Technique (USD Billion)
      1. Ultrasound-Guided Biopsy
      2. Stereotactic Guided Biopsy
      3. MRI-Guided Biopsy
      4. CT Guided Biopsy
      5. Others
    4. Biopsy Devices Market, BY End User (USD Billion)
      1. Hospitals & Clinics
      2. Diagnostic & Imaging Centers
      3. Academic & Research Institutes
      4. Others
    5. Biopsy Devices Market, BY Region (USD Billion)
      1. North America
      2. Europe
      3. APAC
      4. South America
      5. MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. Competitive Landscape
      1. Overview
      2. Competitive Analysis
      3. Market share Analysis
      4. Major Growth Strategy in the Healthcare
      5. Competitive Benchmarking
      6. Leading Players in Terms of Number of Developments in the Healthcare
      7. Key developments and growth strategies
      8. Major Players Financial Matrix
    2. Company Profiles
      1. Becton Dickinson and Company (US)
      2. Boston Scientific Corporation (US)
      3. Medtronic plc (IE)
      4. Hologic, Inc. (US)
      5. Thermo Fisher Scientific Inc. (US)
      6. Abbott Laboratories (US)
      7. Siemens Healthineers AG (DE)
      8. Johnson & Johnson (US)
      9. Cook Medical Incorporated (US)
    3. Appendix
      1. References
      2. Related Reports 6 LIST OF FIGURES
    4. MARKET SYNOPSIS
    5. NORTH AMERICA MARKET ANALYSIS
    6. US MARKET ANALYSIS BY TYPE
    7. US MARKET ANALYSIS BY APPLICATION
    8. US MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    9. US MARKET ANALYSIS BY END USER
    10. CANADA MARKET ANALYSIS BY TYPE
    11. CANADA MARKET ANALYSIS BY APPLICATION
    12. CANADA MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    13. CANADA MARKET ANALYSIS BY END USER
    14. EUROPE MARKET ANALYSIS
    15. GERMANY MARKET ANALYSIS BY TYPE
    16. GERMANY MARKET ANALYSIS BY APPLICATION
    17. GERMANY MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    18. GERMANY MARKET ANALYSIS BY END USER
    19. UK MARKET ANALYSIS BY TYPE
    20. UK MARKET ANALYSIS BY APPLICATION
    21. UK MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    22. UK MARKET ANALYSIS BY END USER
    23. FRANCE MARKET ANALYSIS BY TYPE
    24. FRANCE MARKET ANALYSIS BY APPLICATION
    25. FRANCE MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    26. FRANCE MARKET ANALYSIS BY END USER
    27. RUSSIA MARKET ANALYSIS BY TYPE
    28. RUSSIA MARKET ANALYSIS BY APPLICATION
    29. RUSSIA MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    30. RUSSIA MARKET ANALYSIS BY END USER
    31. ITALY MARKET ANALYSIS BY TYPE
    32. ITALY MARKET ANALYSIS BY APPLICATION
    33. ITALY MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    34. ITALY MARKET ANALYSIS BY END USER
    35. SPAIN MARKET ANALYSIS BY TYPE
    36. SPAIN MARKET ANALYSIS BY APPLICATION
    37. SPAIN MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    38. SPAIN MARKET ANALYSIS BY END USER
    39. REST OF EUROPE MARKET ANALYSIS BY TYPE
    40. REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    41. REST OF EUROPE MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    42. REST OF EUROPE MARKET ANALYSIS BY END USER
    43. APAC MARKET ANALYSIS
    44. CHINA MARKET ANALYSIS BY TYPE
    45. CHINA MARKET ANALYSIS BY APPLICATION
    46. CHINA MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    47. CHINA MARKET ANALYSIS BY END USER
    48. INDIA MARKET ANALYSIS BY TYPE
    49. INDIA MARKET ANALYSIS BY APPLICATION
    50. INDIA MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    51. INDIA MARKET ANALYSIS BY END USER
    52. JAPAN MARKET ANALYSIS BY TYPE
    53. JAPAN MARKET ANALYSIS BY APPLICATION
    54. JAPAN MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    55. JAPAN MARKET ANALYSIS BY END USER
    56. SOUTH KOREA MARKET ANALYSIS BY TYPE
    57. SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    58. SOUTH KOREA MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    59. SOUTH KOREA MARKET ANALYSIS BY END USER
    60. MALAYSIA MARKET ANALYSIS BY TYPE
    61. MALAYSIA MARKET ANALYSIS BY APPLICATION
    62. MALAYSIA MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    63. MALAYSIA MARKET ANALYSIS BY END USER
    64. THAILAND MARKET ANALYSIS BY TYPE
    65. THAILAND MARKET ANALYSIS BY APPLICATION
    66. THAILAND MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    67. THAILAND MARKET ANALYSIS BY END USER
    68. INDONESIA MARKET ANALYSIS BY TYPE
    69. INDONESIA MARKET ANALYSIS BY APPLICATION
    70. INDONESIA MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    71. INDONESIA MARKET ANALYSIS BY END USER
    72. REST OF APAC MARKET ANALYSIS BY TYPE
    73. REST OF APAC MARKET ANALYSIS BY APPLICATION
    74. REST OF APAC MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    75. REST OF APAC MARKET ANALYSIS BY END USER
    76. SOUTH AMERICA MARKET ANALYSIS
    77. BRAZIL MARKET ANALYSIS BY TYPE
    78. BRAZIL MARKET ANALYSIS BY APPLICATION
    79. BRAZIL MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    80. BRAZIL MARKET ANALYSIS BY END USER
    81. MEXICO MARKET ANALYSIS BY TYPE
    82. MEXICO MARKET ANALYSIS BY APPLICATION
    83. MEXICO MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    84. MEXICO MARKET ANALYSIS BY END USER
    85. ARGENTINA MARKET ANALYSIS BY TYPE
    86. ARGENTINA MARKET ANALYSIS BY APPLICATION
    87. ARGENTINA MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    88. ARGENTINA MARKET ANALYSIS BY END USER
    89. REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
    90. REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    91. REST OF SOUTH AMERICA MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    92. REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    93. MEA MARKET ANALYSIS
    94. GCC COUNTRIES MARKET ANALYSIS BY TYPE
    95. GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    96. GCC COUNTRIES MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    97. GCC COUNTRIES MARKET ANALYSIS BY END USER
    98. SOUTH AFRICA MARKET ANALYSIS BY TYPE
    99. SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    100. SOUTH AFRICA MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    101. SOUTH AFRICA MARKET ANALYSIS BY END USER
    102. REST OF MEA MARKET ANALYSIS BY TYPE
    103. REST OF MEA MARKET ANALYSIS BY APPLICATION
    104. REST OF MEA MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    105. REST OF MEA MARKET ANALYSIS BY END USER
    106. KEY BUYING CRITERIA OF HEALTHCARE
    107. RESEARCH PROCESS OF MRFR
    108. DRO ANALYSIS OF HEALTHCARE
    109. DRIVERS IMPACT ANALYSIS: HEALTHCARE
    110. RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    111. SUPPLY / VALUE CHAIN: HEALTHCARE
    112. Biopsy Devices Market, BY TYPE, 2024 (% SHARE)
    113. Biopsy Devices Market, BY TYPE, 2024 TO 2035 (USD Billion)
    114. Biopsy Devices Market, BY APPLICATION, 2024 (% SHARE)
    115. Biopsy Devices Market, BY APPLICATION, 2024 TO 2035 (USD Billion)
    116. Biopsy Devices Market, BY GUIDANCE TECHNIQUE, 2024 (% SHARE)
    117. Biopsy Devices Market, BY GUIDANCE TECHNIQUE, 2024 TO 2035 (USD Billion)
    118. Biopsy Devices Market, BY END USER, 2024 (% SHARE)
    119. Biopsy Devices Market, BY END USER, 2024 TO 2035 (USD Billion)
    120. BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES
    121. LIST OF ASSUMPTIONS
    122. North America MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    123. US MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    124. Canada MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    125. Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    126. Germany MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    127. UK MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    128. France MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    129. Russia MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    130. Italy MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    131. Spain MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    132. Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    133. APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    134. China MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    135. India MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    136. Japan MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    137. South Korea MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    138. Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    139. Thailand MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    140. Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    141. Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    142. South America MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    143. Brazil MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    144. Mexico MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    145. Argentina MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    146. Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    147. MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    148. GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    149. South Africa MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    150. Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY GUIDANCE TECHNIQUE, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    151. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    152. ACQUISITION/PARTNERSHIP

 

Biopsy Devices Market Segmentation

Biopsy Devices Product Type Outlook (USD Billion, 2019-2030)

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Application Outlook (USD Billion, 2019-2030)

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Guidance Outlook (USD Billion, 2019-2030)

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices End User Outlook (USD Billion, 2019-2030)

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Biopsy Devices Regional Outlook (USD Billion, 2019-2030)

North America Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

US Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Canada Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Europe Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Germany Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

France Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

UK Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Italy Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Spain Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Rest Of Europe Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Asia-Pacific Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

China Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Japan Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

India Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

South Korea Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Australia Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Rest of the World Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Middle East Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Africa Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

Latin America Outlook (USD Billion, 2019-2030)

Biopsy Devices Market by Product Type

Biopsy Guns

Biopsy Guidance System

Biopsy Needles

Vacuum-Assisted Biopsy (VAB) Devices

Fine Needle Aspiration Biopsy (FNAB) Devices

Core Needle Biopsy (CNB) Devices

Biopsy Forceps

Localization Wires

Others

Biopsy Devices Market by Application

Breast Biopsy

Prostate Biopsy

Liver Biopsy

Lung Biopsy

Gynecological Biopsy

Others

Biopsy Devices Market by Guidance Technique

Ultrasound-Guided Biopsy

Stereotactic Guided Biopsy

MRI-Guided Biopsy

CT Guided Biopsy

Others

Biopsy Devices Market by End User

Hospitals & Clinics

Diagnostic & Imaging Centers

Academic & Research Institutes

Others

 

 

Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓